NEW YORK, March 12, 2018 /PRNewswire/ -- WeissLaw LLP is
investigating possible breaches of fiduciary duty and other
violations of law by the Board of Directors of Express Scripts
Holding Co. ("ESRX" or the "Company") (NASDAQ: ESRX) in connection
with the proposed acquisition of the Company by Cigna Corp. ("CI")
(NYSE: CI). On March 8, 2018,
the Company announced a definitive agreement for CI to acquire all
outstanding shares of ESRX in a cash-and-stock deal. Under
the terms of the agreement, the Company's shareholders will receive
$48.75 in cash and 0.2434 of a share
of the newly combined company for each ESRX share they own,
representing consideration of $96.03
per share.
WeissLaw is investigating whether ESRX's Board acted to maximize
shareholder value prior to entering into the agreement.
Notably, at least one analyst set a target price of $101.00, or nearly $5.00 above the per-share consideration.
Given these facts, WeissLaw is investigating whether ESRX's
Board acted in the best interests of ESRX's public shareholders to
maximize shareholder value prior to entering into the
agreement. If you own ESRX shares and would like more
information about your rights or our investigation, or if you have
information to share with us, please contact Joshua Rubin by telephone at
(888) 593-4771 or by email at
stockinfo@weisslawllp.com.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com or fill out the
form on our website,
http://www.weisslawllp.com/express-scripts-holding-co/
View original
content:http://www.prnewswire.com/news-releases/weisslaw-llp-investigates-express-scripts-holding-co-acquisition-300612434.html
SOURCE WeissLaw LLP